BioAge Labs: Funding, Investors & Team (Sep 2026)
BIOAGE discovers and develops drugs to treat aging and associated diseases. The company's primary initiative, azelaprag, is an oral APJ agonist on track for Phase 2 trials in conjunction with tirzepatide to potentially become a groundbreaking treatment for obesity in the elderly.
BioAge Labs has raised $285M across 2 funding rounds on record, the most recent an undisclosed round of $115M announced in Jan 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioAge Labs Company Profile and Key Stats
Latest funding round on record: Jan 2026.
BioAge Labs Funding Rounds
BioAge Labs raised $170M in a Series D announced in Feb 2024.
1.9 years later, an undisclosed round of $115M was announced in Jan 2026.
BioAge Labs Founders and Leadership Team
Contact details for the BioAge Labs team: 1 of 2 have an email address on file.
Start 14-day free trial →BioAge Labs Funding Compared to Other Biotechnology Startups
BioAge Labs' latest round of $115M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioAge Labs in Biotechnology and Richmond
Companies Similar to BioAge Labs
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
BioAge Labs Funding FAQs
What does BioAge Labs do?
BIOAGE discovers and develops drugs to treat aging and associated diseases. The company's primary initiative, azelaprag, is an oral APJ agonist on track for Phase 2 trials in conjunction with tirzepatide to potentially become a groundbreaking treatment for obesity in the elderly.
How much funding has BioAge Labs raised?
BioAge Labs has raised $285M across 2 rounds on record. The most recent is an undisclosed round of $115M announced in Jan 2026.
When did BioAge Labs last raise funding?
BioAge Labs' most recent funding round on record is an undisclosed round of $115M, announced in Jan 2026.
Who founded BioAge Labs?
FundedIQ lists Eric Morgen (Founder), Kristen Fortney (Founder) at BioAge Labs.
Where is BioAge Labs headquartered?
BioAge Labs is based in Richmond, California, United States.
How many employees does BioAge Labs have?
BioAge Labs is in the 101-250 employee band.
How does BioAge Labs' funding compare to other Biotechnology startups?
BioAge Labs' latest round of $115M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's BioAge Labs Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioAge Labs is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.